No Detail Found!

Evaluation of efficacy of niosomal clindamycin phosphate 1% solution in comparison to conventional clindamycin phosphate 1% solution in the treatment of acne vulgaris: A randomized controlled trial

Author(s)
Saman Mohammadi Department of Dermatology, Kerman University of Medical Sciences, Iran
Hoda Badakhsh Department of Dermatology, Kerman University of Medical Sciences, Iran
Abbas Pardakhti Department of Pharmaceutics, School of Pharmacy, University of Medical Sciences, Kerman, Iran
Maryam Khalili Department of Dermatology, Kerman University of Medical Sciences, Iran
Rezvan Amiri Department of Dermatology, Kerman University of Medical Sciences, Iran
Azadeh Mohebbi Department of Dermatology, Kerman University of Medical Sciences, Iran
Mahin Aflatoonian Department of Dermatology, Kerman University of Medical Sciences, Iran
Saeedeh Farajzadeh Department of Dermatology, Leishmaniasis Research Center, Kerman University of Medical Sciences, Iran
Abstract
Background Adverse effects including pruritus and erythema as well as increased bacterial resistance have been reported with topical clindamycin. Niosomal structures can lead to improved drug efficacy and decreased side effects because of selective effect on target organ. In this study, we decided to evaluate efficacy of niosomal clindamycin in comparison with conventional form. Methods This study is a double-blinded clinical trial on 100 acne patients divided into 2 groups (50 patients in each group) that has been done from 2014 to 2017 in Kerman, Iran. The efficacy of niosomal clindamycin 1% in comparison with conventional form was evaluated by counting acne lesions and grading acne with Global Acne Grading System. The Chi-square test and student t test were used to determine drug efficacy and side effects. The data were analyzed using SPSS 16 (SPSS Statistics, IBM, Armonk, NY, USA). P value <0.05 was considered significant. Results There was a significant difference between 2 treatment groups in reduction of acne lesions at the end of the study (P<0.05). The mean score of acne according to Global Acne Grading System at the end of the study was 6.64± 3.26 and 8.21±3.42 in niosomal and control group, respectively and this difference was statistically significant(P=0.023). Conclusion Niosomal clindamycin has higher efficacy without increased adverse effects than conventional type. So, we can use niosomal form in treatment of inflammatory acne lesions, particularly in patients with low adherence to treatment and high expectations from treatment.
Publication Details
Page(s) 64-71
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 30, Issue: 1, Year: 2020

Request the full text from PASTIC

Keywords
clindamycin, Niosomes, acne
0

Citations

0

Downloads

61

Views